A biorepository for cancer research and precision medicine

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Caris Biorepository collects and stores biological specimens and clinical data to support research aimed at advancing precision medicine in cancer care. This observational project aims to provide researchers and healthcare professionals with access to high-quality human specimens and associated data, facilitating the correlation of clinical outcomes with biospecimen information. By maintaining the integrity and relevance of these specimens, the biorepository seeks to enhance drug development, clinical trials, and healthcare policies. The initiative fosters collaboration among various entities, including government, academia, and industry, to improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Capacity to provide informed consent

Exclusion Criteria:

* Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository.
* Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults.
* Individuals who lack the capacity to give informed consent

Where it's running

• University of South Alabama
  Mobile, Alabama, United States Recruiting
• Southwest Medical Imaging
  Scottsdale, Arizona, United States Recruiting
• St. Bernards Medical Center
  Jonesboro, Arkansas, United States Recruiting
• CARTI Cancer Center
  Little Rock, Arkansas, United States Recruiting
• ObjectiveHealth - ARcare Center for Clinical Research
  Little Rock, Arkansas, United States Recruiting
• Lee Memorial Health System
  Fort Myers, Florida, United States Recruiting

Study contacts

• Principal investigator: Matthew Oberley, MD — Caris Life Sciences
• Study coordinator: Mary Baker
• Email: carisresearch@carisls.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Patient-specific MRD liquid biopsy for resected NSCLC

  This study tests a personalized MRD blood and bronchial washing test after surgery to see if it can signal recurrence earlier in people with resected NSCLC.

  Recruiting Yonsei University · Yongin-si, Gyeonggi-do and 2 other locations · NCT07921888

• Methylation markers in self-samples to help detect gynecological cancers

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902375

• ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer

  A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.

  Recruiting Masaryk Memorial Cancer Institute · Brno, Czech Republic · NCT07895459

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.